Notes - Segment Information, Etc.

Oncolys BioPharma Inc. - Filing #7269903

Concept 2024-01-01 to
2024-12-31
Notes - Segment information, etc.
Information about gain on bargain purchase for each reportable segment
Description of factors which led to recognition of gain on bargain purchase for each reportable segment

【報告セグメントごとの負ののれん発生益に関する情報】

当社は、創薬事業の単一セグメントであるため、記載を省略しております。

 

Talk to a Data Expert

Have a question? We'll get back to you promptly.